. . . . . . . . . . . . . . . . . . "TextLocation" . "Abstract" . "a(SCHEM:\"PD 98,059\") -| (p(RGD:Igf1) -> bp(GO:\"skeletal muscle hypertrophy\"))" . "p(RGD:Igf1) -> bp(GO:\"skeletal muscle hypertrophy\")" . "Approximately 2000 hand curated statements drawn from 57 PubMeds." . "Copyright (c) 2011-2012, Selventa. All Rights Reserved." . "BEL Framework Small Corpus Document" . "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License" . . "1.6" . "Our results show that 14 days of coinfusion of MAPK/ERK kinase inhibitor PD-098059\n(PD) limited the phosphorylation of ERK and prevented IGF-I induced increases\nin protein (18%, P < 0.05 vs. 7%, not significant) or myofibrillar protein (23%,\nP < 0.01 vs. 5%, not significant)." . . "support@belframework.org" . "Selventa" . . . . "2014-07-03T14:29:34.184+02:00"^^ . . .